Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $133.60, but opened at $143.4960. Pro Medicus shares last traded at $143.4960, with a volume of 328 shares trading hands.
Analyst Ratings Changes
Separately, Jefferies Financial Group lowered Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $155.00.
View Our Latest Stock Report on Pro Medicus
Pro Medicus Stock Performance
About Pro Medicus
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Recommended Stories
- Five stocks we like better than Pro Medicus
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
- Sociedad Química y Minera’s Lithium Boom Is Back, But Iodine Steals the Show
- Forget Chips: These 3 Stocks Are Building the AI Data Center Boom
- AIxCrypto Dumps Its Crypto and Goes All In on Robotics
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
